A. Ruiz‐Extremera

2.2k total citations · 1 hit paper
65 papers, 1.6k citations indexed

About

A. Ruiz‐Extremera is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, A. Ruiz‐Extremera has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 25 papers in Hepatology and 11 papers in Genetics. Recurrent topics in A. Ruiz‐Extremera's work include Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis B Virus Studies (14 papers). A. Ruiz‐Extremera is often cited by papers focused on Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis B Virus Studies (14 papers). A. Ruiz‐Extremera collaborates with scholars based in Spain, United States and Colombia. A. Ruiz‐Extremera's co-authors include Javier Salmerón, A. Gila, R. Quiles, Josefa León, Paloma Muñoz‐de‐Rueda, M. Diago, Manuel Romero‐Gómez, Raúl J. Andrade, Jorge Casado and Conrado Fernández‐Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

A. Ruiz‐Extremera

64 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

2005 556 citations Manuel Romero‐Gómez, Raúl J. Andrade et al. profile →

Peers

Countries citing papers authored by A. Ruiz‐Extremera

Since Specialization

Citations

This map shows the geographic impact of A. Ruiz‐Extremera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ruiz‐Extremera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ruiz‐Extremera more than expected).

Fields of papers citing papers by A. Ruiz‐Extremera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ruiz‐Extremera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ruiz‐Extremera. The network helps show where A. Ruiz‐Extremera may publish in the future.

Co-authorship network of co-authors of A. Ruiz‐Extremera

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ruiz‐Extremera. A scholar is included among the top collaborators of A. Ruiz‐Extremera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ruiz‐Extremera. A. Ruiz‐Extremera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Method for Selecting Basophils Might Be Determinant in the Basophil Activation Test in Patients With Mastocytosis 2019 ·Journal of Investigational Allergology and Clinical Immunology ·José Miguel Urra, (unknown), A. Ruiz‐Extremera, Feo F, Teresa Alfaya	6
2	Estudio de casos y controles sobre hiperlaxitud articular generalizada en escolares con trastornos digestivos funcionales según los criterios de roma IV en español 2019 ·Anales de Pediatría ·Carlos Alberto Velasco Benítez, A. Ruiz‐Extremera, Miguel Saps	3
3	Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children 2017 ·PLoS ONE ·A. Ruiz‐Extremera, (unknown), Mário Florido, Paloma Muñoz de Rueda, (unknown), Jorge Casado, (unknown), R. Quiles, (unknown), A. Gila, Juan de Dios Luna, Josefa León, Javier Salmerón	8
4	Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento 2016 ·Medicina Clínica ·José Antonio Muñoz‐Gámez, Javier Salmerón, A. Ruiz‐Extremera	4
5	Effects of manual therapy on treatment duration and motor development in infants with severe nonsynostotic plagiocephaly: a randomised controlled pilot study 2016 ·Child s Nervous System ·Irene Cabrera‐Martos, Maríe Carmen Valenza, Gerald Valenza‐Demet, (unknown), (unknown), A. Ruiz‐Extremera	24
6	Impact of Torticollis Associated With Plagiocephaly on Infants’ Motor Development 2015 ·Journal of Craniofacial Surgery ·Irene Cabrera‐Martos, Maríe Carmen Valenza, Gerald Valenza‐Demet, (unknown), (unknown), A. Ruiz‐Extremera	15
7	Utilización de fármacos en niños en cuidados intensivos: estudio de las prescripciones off-label 2015 ·Medicina Intensiva ·Encarnación Blanco‐Reina, (unknown), (unknown), Ricardo Ocaña‐Riola, (unknown), A. Ruiz‐Extremera	19
8	Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticles 2013 ·Colloids and Surfaces B Biointerfaces ·K. Rudzka, M. López-Viota, José Antonio Muñoz‐Gámez, (unknown), A. Ruiz‐Extremera, Á.V. Delgado	24
9	Importance of IL-10 and IL-6 during chronic hepatitis c genotype-1 treatment and their relation with IL28B 2012 ·Cytokine ·(unknown), Paloma Muñoz‐de‐Rueda, (unknown), A. Gila, R. Quiles, (unknown), Ángel Carazo, (unknown), A. Ruiz‐Extremera, Javier Salmerón	16
10	Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. 2012 ·PubMed ·Teresa Caballero, A. Gila, (unknown), (unknown), Josefa León, (unknown), (unknown), (unknown), (unknown), A. Ruiz‐Extremera, (unknown)	13
11	Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluation 2012 ·Materials Science and Engineering C ·M. López-Viota, (unknown), (unknown), K. Rudzka, (unknown), A. Ruiz‐Extremera, Javier Salmerón, Á.V. Delgado	33
12	Plasma Ribavirin Trough Concentrations During Treatment of Chronic Hepatitis C in Genotype-1 Patients 2011 ·Journal of Clinical Gastroenterology ·(unknown), A. Ruiz‐Extremera, (unknown), R. Quiles, Ana Belén Barragán Martín, M. Diago, Raúl J. Andrade, J.M. Navarro, A. Gila, Josefa León, Ángel Carazo, (unknown), Javier Salmerón	5
13	Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children 2011 ·Hepatology ·A. Ruiz‐Extremera, José Antonio Muñoz‐Gámez, (unknown), Paloma Muñoz de Rueda, R. Quiles, (unknown), Jorge Casado, Ana Belén Barragán Martín, (unknown), Ángel Carazo, Esther J. Pavón, (unknown), Josefa León, Javier Salmerón	95
14	Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells 2010 ·Cancer Letters ·José Antonio Muñoz‐Gámez, R. Quiles, A. Ruiz‐Extremera, (unknown), (unknown), (unknown), Josefa León, F. Javier Oliver, Javier Salmerón	23
15	Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon–ribavirin 2008 ·Journal of Clinical Virology ·Javier Salmerón, Jorge Casado, Paloma Muñoz de Rueda, Víctor de Lafuente, M. Diago, Manuel Romero‐Gómez, (unknown), Josefa León, A. Gila, R. Quiles, Luis M. Rodríguez, A. Ruiz‐Extremera	14
16	Induction doses of interferon‐α‐2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non‐responders to interferon monotherapy: a randomized trial 2006 ·Journal of Viral Hepatitis ·Javier Salmerón, M. Diago, Raúl J. Andrade, Ramón Pérez, R. Solà, Míriam Romero, Manuel de la Mata, Rafael Granados, A. Ruiz‐Extremera, (unknown)	4
17	Quasispecies as Predictive Response Factors for Antiviral Treatment in Patients with Chronic Hepatitis C 2006 ·Digestive Diseases and Sciences ·Javier Salmerón, Paloma Muñoz de Rueda, A. Ruiz‐Extremera, Jorge Casado, Carlos Huertas, (unknown), Luis M. Rodríguez, (unknown)	7
18	Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial 1999 ·Liver International ·Javier Salmerón, A. Ruiz‐Extremera, (unknown), (unknown), (unknown), (unknown), (unknown)	28
19	Low-dosage prophylactic vancomycin in central-venous catheters for neonates 1998 ·Early Human Development ·(unknown), A. Ruiz‐Extremera, (unknown), (unknown), (unknown), (unknown), Javier Salmerón	9
20	Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors 1996 ·Digestive Diseases and Sciences ·(unknown), (unknown), Mercedes Pérez-Ruiz, (unknown), Salvador Oyonarte, (unknown), A. Ruiz‐Extremera	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact